These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10473495)

  • 1. Early trials of angiogenic factors have not targeted patients most at risk of ocular disease.
    McKibbin M; O'Neill D
    BMJ; 1999 Sep; 319(7210):643-4. PubMed ID: 10473495
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factors influencing ocular angiogenesis].
    Neroev VV; Sarygina OI; Levkina OA
    Vestn Oftalmol; 2009; 125(3):52-5. PubMed ID: 19566051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of ocular vascular disorders.
    Garner A
    Aust J Ophthalmol; 1984 Nov; 12(4):401-4. PubMed ID: 6084992
    [No Abstract]   [Full Text] [Related]  

  • 4. Cataract surgery using phacoemulsification may reactivate angiogenic growth factors in ocular ischaemic syndrome.
    Zaidi FH; Sharkawi E; Weir R; King ER
    Eye (Lond); 2005 Jun; 19(6):706-9. PubMed ID: 15332098
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular involvement in paediatric haemolytic uraemic syndrome.
    Sturm V; Menke MN; Landau K; Laube GF; Neuhaus TJ
    Acta Ophthalmol; 2010 Nov; 88(7):804-7. PubMed ID: 19604154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.
    Friedlander M; Theesfeld CL; Sugita M; Fruttiger M; Thomas MA; Chang S; Cheresh DA
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9764-9. PubMed ID: 8790405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular neovascularization: an epidemiologic review.
    Lee P; Wang CC; Adamis AP
    Surv Ophthalmol; 1998; 43(3):245-69. PubMed ID: 9862312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic disk and iris neovascularization after surgical interruption of the retinal circulation.
    Hutchins RK; Gittinger JW; Weiter JJ
    Am J Ophthalmol; 1986 May; 101(5):616-8. PubMed ID: 2422940
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.
    Miller JW; Adamis AP; Shima DT; D'Amore PA; Moulton RS; O'Reilly MS; Folkman J; Dvorak HF; Brown LF; Berse B
    Am J Pathol; 1994 Sep; 145(3):574-84. PubMed ID: 7521577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cases reported at the FAN club meeting, Bonn, November 1984. Case 3. Retinitis pigmentosa and retinal neovascularization.
    Uliss AE; Gregor ZJ
    Int Ophthalmol; 1985 Nov; 8(4):221-3. PubMed ID: 2417970
    [No Abstract]   [Full Text] [Related]  

  • 11. Antivascular endothelial growth factors in anterior segment diseases.
    Scholl S; Kirchhof J; Augustin AJ
    Dev Ophthalmol; 2010; 46():133-139. PubMed ID: 20703039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ocular ischemic syndrome and neovascularization.
    Brown GC; Brown MM; Magargal LE
    Trans Pa Acad Ophthalmol Otolaryngol; 1986; 38(1):302-6. PubMed ID: 2429407
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathologic findings in anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy.
    Lewis H; Abrams GW; Foos RY
    Am J Ophthalmol; 1987 Dec; 104(6):614-8. PubMed ID: 2446502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic angiogenesis.
    Henry TD
    BMJ; 1999 Jun; 318(7197):1536-9. PubMed ID: 10356013
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical management of cosmetic extended-wear contact lens failure.
    Weissman BA; Pearson TR
    J Am Optom Assoc; 1986 Jun; 57(6):448-50. PubMed ID: 2424962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Applications of interferon in ophthalmological field and its ocular complications].
    Matsui M
    Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):511-2. PubMed ID: 7518187
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular ischemic syndrome.
    Mizener JB; Podhajsky P; Hayreh SS
    Ophthalmology; 1997 May; 104(5):859-64. PubMed ID: 9160035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic eye disease: a primary care perspective.
    Frank KJ; Dieckert JP
    South Med J; 1996 May; 89(5):463-70. PubMed ID: 8638169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular complications of diabetes mellitus--classification and diagnosis].
    Matsui M
    Nihon Rinsho; 1991 Feb; 49 Suppl():269-74. PubMed ID: 1709705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.